ScholarWorks@Hanyang University: An, Ji hyun

Detailed Information

An, Ji hyun (안지현)

COLLEGE OF MEDICINE (DEPARTMENT OF INTERNAL MEDICINE)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Hepatocellular carcinoma:7||Treatment:5||hepatocellular carcinoma:5||Liver cancer:3||Liver neoplasms:3||Surveillance:3||HBV:2||Carcinoma:2||Transarterial chemoembolization:2||HCC:2||Cirrhosis:2||liver cancer:2||Nonalcoholic fatty liver disease:2||Atherosclerosis:2||CT:2||Viral hepatitis:2||Prognosis:2||Stroke:2||Survival:2||FOXO1:1||G alpha(12):1||G protein:1||GGT:1||GPCR:1||Gadoxetic Acid:1||Guideline:1||HBsAg:1||Hepatectomy:1||Hepatitis B:1||Hepatitis B Virus:1||Hepatitis B surface antigen:1||Hepatitis B virus:1||Hepatitis C Virus:1||Hepatocellular:1||Hepatolithiasis:1||Hilar cholangiocarcinoma:1||Immune:1||Incidence rate:1||KASL guidelines:1||Korea:1||Liver Cancer:1||Liver cirrhosis:1||Liver transplantation:1||Living donor liver transplantation:1||Local:1||MRI:1||Management:1||Metroticket calculator:1||NA:1||Neoplasm recurrence:1||Nonantidiabetic drugs:1||Noncoding small RNA:1||Nonalcoholic steatohepatitis:1||Noninvasive fibrosis score:1||Obstructive jaundice:1||Outcome:1||PD1:1||PDL1:1||Peginterferon:1||Peliosis hepatis:1||Portal hypertension:1||Portal vein:1||Portal vein thrombosis:1||Prospective studies:1||Quality control system:1||Radiation therapy:1||Radiotherapy:1||Recurrence:1||Resection:1||Resistance:1||Risk factor:1||Sequencing:1||Sonography:1||Survival rate:1||Therapeutics:1||Threedimensional printing:1||Threedimensional visualization:1||Transplantation:1||Tumor doubling time:1||Ultrasound:1||Validation:1||Variceal bleeding:1||Virologic breakthrough:1||Virologic response:1||aetiology:1||alphafoetoprotein:1||alternative lengthening of telomeres:1||antiviral prophylaxis:1||breast neoplasms:1||cMet:1||cancer:1||chemotherapy:1||chromophobe:1||chronic hepatitis C:1||clinical features:1||clustering:1||colonic neoplasms:1||coronary artery disease, prevalence:1||coronary computed tomography angiography:1||decompensated liver cirrhosis:1||directacting agent:1||directacting antiviral:1||elderly:1||entecavir:1||family:1||hepatitis B virus:1||hepatitis B virus core antibody IgG:1||hepatitis C virus:1||hepatobiliary cancer:1||hepatocellular:1||liver cirrhosis, asymptomatic:1||lymphoma:1||methionine adenosyltransferase:1||nomogram:1||nonB nonC hepatocellular carcinoma:1||noncoding RNA:1||occult hepatitis B virus infection:1||overall survival:1||posttreatment:1||prognosis:1||prostatic neoplasms:1||protease inhibitor:1||quality of life:1||reactivation:1||recurrence:1||relapse:1||resection:1||survival:1||treatment:1||BCLC:1||Bile duct invasion:1||CTLA4:1||Cancer:1||Cerebrovascular disorder:1||Chronic hepatitis B:1||Clinical trials:1||Combined Image Analyses:1||Computed tomography:1||Consensus:1||Contrast agents:1||Costeffectiveness:1||Disease management:1||Drugs:1||Early detection of cancer:1||Entecavir:1||EpsteinBarr virus:1||Esophageal varices:1||

STATISTICS: Total View :5,018,169; Today View :5,646

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE